Health-related quality of life among anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) patients treated with first- and next-generation ALK tyrosine kinase inhibitors (TKIs): a systematic review and meta-analysis. [PDF]
Huang Y, Chu Q, Wang J, Zhang L.
europepmc +1 more source
Iruplinalkib for G1202R-mutant non-small cell lung cancer with anaplastic lymphoma kinase double fusion failed to alectinib: a case report. [PDF]
Yang G +6 more
europepmc +1 more source
Anaplastic lymphoma kinase as a new therapeutic target in inflammatory itch. [PDF]
Voisin T, Labit E, Gaudenzio N, Basso L.
europepmc +1 more source
Intratumoral and peritumoral CT radiomics in predicting anaplastic lymphoma kinase mutations and survival in patients with lung adenocarcinoma: a multicenter study. [PDF]
Chen W +14 more
europepmc +1 more source
Delayed Bronchopleural Fistula Formation Following Salvage Surgery of Stage IV Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer. [PDF]
Barter L +4 more
europepmc +1 more source
Survival prediction of anaplastic large cell lymphoma-anaplastic lymphoma kinase positive: Based on an ensemble machine learning model. [PDF]
Zhong R, Liang C, Li L.
europepmc +1 more source
Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review. [PDF]
Hu T +11 more
europepmc +1 more source
The Use of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer Treatment-Literature Review. [PDF]
Gorzelak-Magiera A +3 more
europepmc +1 more source
Immunophenotypic Shift From CD8 to CD4 With Anaplastic Lymphoma Kinase (ALK)-Negative Anaplastic Large Cell Transformation in Mycosis Fungoides: A Case Report. [PDF]
Chan TH, Harris R, Sidhu JS.
europepmc +1 more source
Hyperbilirubinemia in a Patient Receiving Alectinib for Anaplastic Lymphoma Kinase Positive Non-Small-Cell Lung Cancer: A Histological Features. [PDF]
Zhang Q +5 more
europepmc +1 more source

